Literature DB >> 427063

The significance of abnormal glucose tolerance (hyperglycaemia and hypoglycaemia) in pregnancy.

D A Abell.   

Abstract

Maternal hypoglycaemia (plasma glucose below 5th centile) had a highly significant association with fetal growth retardation, and perinatal mortality was significantly increased in the presence of both hypoglycaemia and hyperglycaemia (plasma glucose above 95th centile) when pregnancy outcome was analyzed in 5000 consecutive patients who had a glucose tolerance test performed during the third trimester of pregnancy. This study confirms the significance of abnormal glucose tolerance as a causative factor of feto-placental dysfunction. The flat glucose tolerance test pattern had no significance beyond the presence of associated hypoglycaemia, but reactive hypoglycaemia, and persistent abnormalities of plasma glucose levels during the test, were associated with higher incidences of complicated outcome. Hypertonic dextrose therapy administered to the patient with persistently subnormal urinary oestriol excretion was less likely to cause a favourable response in oestriol excretion if glucose tolerance was abnormal, perhaps because the adverse influences of abnormal glucose tolerance were not reversible by the third trimester of pregnancy. Hypoglycaemia and hyperglycaemia, additional to diabetes mellitus, are significant factors in the aetiology and diagnosis of abnormal pregnancy, and point to the need to investigate therapeutic measures.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 427063     DOI: 10.1111/j.1471-0528.1979.tb10596.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  2 in total

1.  Flat Oral Glucose Tolerance Test During Pregnancy: Maternal Characteristics and Risk for Adverse Outcomes.

Authors:  Amir Naeh; Renana Wilkof-Segev; Anat Jaffe; Esther Maor-Sagie; Mordechai Hallak; Rinat Gabbay-Benziv
Journal:  Clin Diabetes       Date:  2021-07

2.  Does hypoglycemia following a glucose challenge test identify a high risk pregnancy?

Authors:  Suzanne K Pugh; Dorota A Doherty; Everett F Magann; Suneet P Chauhan; James B Hill; John C Morrison
Journal:  Reprod Health       Date:  2009-07-14       Impact factor: 3.223

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.